Internal restructuring
Location of affected unit(s)
Roanne,  Aurillac, Le Plessis-Robinson, Orange, Chasseneuil-du-Poitou, Illkirch-Graffenstaden, Chantepie, Durtal, Witry-lès-Reims and Seynod
Wholesale Trade, Except Of Motor Vehicles And Motorcycles
Wholesale Of Household Goods
46.46 - Wholesale of pharmaceutical goods

135 - 226 jobs
Number of planned job losses
Job loss
74 jobs
Number of planned job creations
Job creation
Announcement Date
8 July 2020
Employment effect (start)
1 September 2020
Foreseen end date
31 December 2020


The leader in pharmaceutical distribution, OCP Répartition, has announced a reorganisation that could lead to 226 job cuts in France. An employment safeguard plan (PSE) was presented to employee representatives on 8 July 2020. After 3 months, the central works council will give a final opinion on this plan and the first departures will take place.  Of the 226 redundancies envisaged, 135 correspond to job cuts and 91 to proposals to modify the employment contract (such as a move to part-time work), which, if the employee refuses, could lead to redundancies. At the same time, the group announced 74 job creations, mostly part-time. A total of five sites are affected by a closure: Aurillac (Cantal), Orange (Vaucluse), Roanne (Loire), Plessis-Robinson (Hauts-de-Seine) and Poitiers (Vienne). Job cuts are also planned at other sites. The reason given by the company for this reorganisation is the deterioration of its current result before tax between 2016 and 2020. The boom in generic drugs at below-market prices is leading to a deficit of €100 million for wholesale distributors, according to the management.



Eurofound (2020), OCP Répartition, Internal restructuring in France, factsheet number 101521, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/101521.